Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Coast first casualty in US overhaul of IRB system

May 5, 2009 Research and Development FDA, US

A US company offering institutional review board services to sponsors of clinical trials has been forced to close its doors …
News

Biotech partnering in the credit crunch

May 1, 2009 Research and Development biotech, partnering, pharma

Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …
Feature

Avastin fails in colon cancer study

April 30, 2009 Research and Development Cancer, Roche

Roche's blockbuster Avastin has failed to show success in treating early-stage colon cancer. A phase III trial found Avastin (bevacizumab) …
News

Sanofi makes cuts to phase III pipeline

April 30, 2009 Research and Development Sanofi-Aventis

Sanofi-Aventis has suspended development of four late-stage drugs and ten other projects following an R&D review. The decision was announced …
News

NICE could ease QALY to boost innovation

April 30, 2009 Research and Development NICE

NICE could be set to dramatically change its cost-effectiveness measure and help boost innovation in the UK, according to Sir …
News

Minister thanks pharma for help in swine flu fight

April 30, 2009 Research and Development h1n1

Health secretary Alan Johnson kept an appointment to address the ABPI's annual conference yesterday despite the spread of swine flu …
News

Developing health, developing profits

April 30, 2009 Research and Development, Sales and Marketing Pfizer, healthcare, working poor

Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …
Feature

Nexavar fails in melanoma study

April 30, 2009 Research and Development Bayer, Cancer, Nexavar

Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …
News

Microdosing shows its mettle in cancer study

April 29, 2009 Research and Development Microdosing

Newly-released data has added additional weight to the evidence for microdosing studies as a means to predict whether or not …
News

UK scientists to examine swine flu

April 29, 2009 Research and Development h1n1

UK scientists will examine new samples of swine influenza as part of the global race to develop a vaccine against …
News

GSK pledges help in flu outbreak

April 28, 2009 Research and Development GSK, h1n1

GlaxoSmithKline has pledged to closely monitor the swine flu outbreak that began in Mexico, and assist in access to treatment …
News

Pfizer taps UCL for stem cell expertise

April 28, 2009 Research and Development Pfizer, UCL, ophthalmology, regenerative medicine

 Pfizer will work with researchers from University College London in the UK to try to develop stem cell-based therapies for …
News

AZ’s Iressa to make comeback

April 28, 2009 Research and Development, Sales and Marketing AZ, Iressa

AstraZeneca's Iressa is set to make a comeback after a European committee recommended its use for a sub-group of lung …
News

GSK and Pfizer joint venture more than a defensive move

April 27, 2009 Research and Development, Sales and Marketing GSK, Pfizer

GSK and Pfizer have agreed to merge their respective HIV businesses, creating a single specialist entity with total pro-forma sales …
News

Strong prospects for Novartis cancer drug, say analysts

April 24, 2009 Research and Development, Sales and Marketing Afinitor, Novartis

The FDA has approved Novartis's Afinitor for advanced renal cell carcinoma patients who have progressed after first-line Sutent or Nexavar …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026